Maximum quantity allowed is 999
请选择数量
CAS RN: 380843-75-4 | 产品编码: B4824
Bosutinib
×
![]()
×
纯度/分析方法: >95.0%(T)(HPLC)
别名：
- 博舒替尼
- 4-[(2,4-二氯-5-甲氧基苯基)氨基]-6-甲氧基-7-[3-(4-甲基-1-哌嗪基)丙氧基]-3-喹啉甲腈
- 4-(2,4-二氯-5-甲氧基苯胺基)-6-甲氧基-7-[3-(4-甲基-1-哌嗪基)丙氧基]-3-喹啉甲腈
- SKI-606
- 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile
- 4-(2,4-Dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile
产品文档：
| 产品编码 | B4824 |
| 纯度/分析方法 | >95.0%(T)(HPLC) |
| 分子式/分子量 | C__2__6H__2__9Cl__2N__5O__3 = 530.45 |
| 外观与形状（20°C） | 固体 |
| 储存温度 | 室温 (15°C以下阴凉干燥处) |
| 储存在惰性气体下 | 存放于惰性气体之中 |
| 应避免的情况 | 空气,湿气 (吸湿) |
| 包装和容器 | 250MG-Glass Bottle with Plastic Insert （查看图片） |
| CAS RN | 380843-75-4 |
| Reaxys-RN | 9100307 |
| MDL编号 | MFCD07367846 |
技术规格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(Volumetric Analysis) | min. 95.0 % |
| Water | max. 5.0 % |
| NMR | confirm to structure |
物性（参考值）
| 熔点 | 120 °C |
| 水溶性 | 不溶 |
| 在水中的溶解度 | 7 mg/l 25 °C |
GHS
| 象形图 |
|
| 信号词 | Warning |
| 危险性说明 | H302 : Harmful if swallowed. H320 : Causes eye irritation. H317 : May cause an allergic skin reaction. H413 : May cause long lasting harmful effects to aquatic life. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P273 : Avoid release to the environment. P272 : Contaminated work clothing should not be allowed out of the workplace. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相关法规
| RTECS# | VB0990000 |
运输信息
| HS编码* | 2933.59-000 |
应用
Bosutinib: A Potent ATP-Competitive Tyrosine Kinase Inhibitor
Bosutinib (SKI-606) is a potent ATP-competitive tyrosine kinase inhibitor. Bosutinib has been reported to inhibit the Bcr-Abl kinase, which promotes chronic myeloid leukemia (CML). Inhibition of Bcr-Abl tyrosine kinase activity or signaling proteins activated by Bcr-Abl in CML cells blocks proliferation and causes apoptotic cell death. Bosutinib is also inhibits the phosphorylation of cellular signaling proteins, including Src-family kinases (Src, Lyn, and Hck) and STAT5. (The product is for research purpose only.)
References
- SKI-606, a 4-Anilino-3-quinolinecarbonitrile Dual Inhibitor of Src and Abl Kinases, Is a Potent Antiproliferative Agent against Chronic Myelogenous Leukemia Cells in Culture and Causes Regression of K562 Xenografts in Nude Mice
- In vitro and in vivo Activity of SKI-606, a Novel Src-Abl Inhibitor, against Imatinib-Resistant Bcr-Abl+ Neoplastic Cells
- Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells
- Bosutinib: A Potent Second-Generation Tyrosine Kinase Inhibitor (a review)
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。